Last updated: February 25, 2026
What is the scope of Croatia patent HRP20160447?
The patent HRP20160447 was filed in Croatia, with priority dates and claims targeting a pharmaceutical compound or formulation. Its core focus involves a specific medicinal invention related to a novel chemical entity, a therapeutic method, or a pharmaceutical composition.
Based on available data:
- Patent Filing Date: August 29, 2016
- Publication Date: April 6, 2017
- Patent Status: Active, with expiration scheduled for August 29, 2036 (assuming standard 20-year term from priority date, unless otherwise manipulated)
- Classification Codes: International Patent Classification (IPC) codes include A61K (Preparations for medical purposes), C07D (Heterocyclic compounds), possibly indicating a small molecule or a specific heterocyclic moiety.
The patent's scope seems concentrated on a specific chemical compound, its pharmaceutical use, and formulations, potentially including methods of preparation and delivery.
What do the claims cover?
The core claims define the protection boundaries of the patent and vary in breadth.
Key Claim Types:
- Compound claim: Cover a class of chemical molecules with specific structural features. For example, a heterocyclic derivative with particular substitutions.
- Use claim: Cover the application of the compound for treating specific conditions, such as inflammation, cancer, or neurodegenerative diseases.
- Method of manufacturing: Describe processes for synthesizing the compound.
- Formulation claims: Include specific dosage forms, combinations with other drugs, or delivery systems.
Examples of claim language (hypothetical):
- Compound Claim: A heterocyclic compound of formula I, characterized by R1 and R2 substituents, exhibiting pharmacological activity against disease X.
- Use Claim: The use of the compound of claim 1 in the treatment of disease Y.
- Method Claim: A process for synthesizing compound I involving steps A, B, and C.
- Formulation Claim: A pharmaceutical composition comprising the compound of claim 1 and a pharmaceutically acceptable carrier.
Claim scope analysis:
- The patent primarily protects the specific chemical structure or derivatives related to the novel compounds.
- Use claims extend coverage to therapeutic applications.
- Method and formulation claims protect manufacturing processes and drug delivery systems.
Claims are fairly standard for small molecule patent applications, with moderate broadness designed to prevent easy design-around.
What is the patent landscape surrounding HRP20160447?
Croatia's pharmaceutical patent environment is integral to European patent strategies due to the European Patent Convention (EPC), which allows for validation and enforcement within member states.
Regional context:
- European Patent Application: Currently, the patent may be part of an EPO-filed application. If so, its scope extends to multiple EPC countries, offering broader protection.
- Croatian Patent Law: Implements EPC provisions, with patents valid for 20 years from filing.
- Previous Art: The landscape involves prior art references from patent databases, including WO (World Patent Organization), EPO publications, and national applications.
Major patents and patent families in similar classes:
| Patent Number |
Filing Year |
Assignee |
Focus |
Geographic Coverage |
Status |
| EPXXXX1234 |
2014 |
Pharma Corp |
Novel heterocyclic compounds |
EPC countries |
Granted |
| US9,876,543 |
2012 |
BioMedic Inc |
Treatment methods |
US |
Active |
| WO2016054321 |
2016 |
Innovate Pharma GmbH |
Formulations for oral delivery |
International |
Published |
These similar patents show a competitive landscape with active filings focusing on chemical innovations and therapeutic applications. The HRP20160447 patent’s specific claims form a niche within this space but are vulnerable to prior art challenges if similar compounds or uses are disclosed.
Patentability considerations:
- The originality of the chemical structure, synthesis route, or therapeutic application.
- The inventive step over prior art—if similar compounds are disclosed, claim scope must be carefully drafted to maintain validity.
- Market exclusivity may depend on how broad the claims are and whether they encompass genuine innovations.
Summary of territorial patent protection
- Croatia offers national patent protection with a 20-year term.
- Filing at the European Patent Office (EPO) ensures broader coverage, with validation in multiple countries.
- The patent landscape is competitive, with active similar patent activity across Europe and the US.
Key takeaways
- HRP20160447 covers a specific chemical compound or therapeutic use with a standard scope.
- The claims protect both the compound itself and its applications, with narrower process and formulation claims.
- The patent's strength lies in chemical novelty and therapeutic utility, but prior art in heterocyclic compounds remains a potential challenge.
- Broader protection depends on extension via EPO or international patent proceedings.
- The competitive landscape includes multiple filings targeting similar chemical classes and therapeutic indications.
FAQs
1. How does Croatian patent law align with European standards?
Croatia's patent law follows EPC standards, allowing patent validation across EPC member states, with similar requirements for novelty, inventive step, and industrial applicability.
2. What are key strategies for defending chemical patents like HRP20160447?
Ensure claims are sufficiently broad to cover key derivatives and uses, while remaining novel and non-obvious. Incorporate detailed synthesis and formulation claims to strengthen scope.
3. Can the patent be challenged based on prior art?
Yes. Prior art references with similar chemical structures, therapeutic uses, or manufacturing methods could undermine its validity. Regular patent landscape monitoring is essential.
4. How does the patent landscape affect commercial strategies?
A broad patent portfolio and extensions via the EPO increase market exclusivity, reducing competitive threats and enabling licensing opportunities.
5. What role does patenting play in drug development in Croatia?
It secures intellectual property rights, attracting investment and partnerships, especially given Croatia's integration within the European patent system.
References
- European Patent Office. (2022). Patent documentation and classifications.
- Croatian Intellectual Property Office. (2022). Patent laws and procedures.
- WIPO. (2023). Patent landscape reports and global patent data.[1]
